The results of this study will give us insight into whether the SAW nebuliser requires more optimisation or if it is ready for further in vivo study with therapeutic agents.
The study is being conducted at St George Hospital (February to March 2019) by researchers from St George Hospital, School of Pharmacy at the University of Sydney and School of Engineering at the RMIT University.
If you agree to participate in this study, you will be asked to sign the Participant Consent Form. You will then be asked to attend the Department of Nuclear Medicine at St George Hospital on a maximum of 2 occasions.
You will be reimbursed for your time and reasonable travel expenses to the amount of $35 per visit.
Ethics approval: HREC/18/RPAH/390
You may be eligible to participate in this study if you: